Comparison of insulin sensitivity, glucose sensitivity, and first phase insulin secretion in patients treated with repaglinide or gliclazide

Archives of Pharmacal Research

Volumn 33, Issue 3, 2010, Pages 411-416

  Wu, Chung Ze ^a   Pei, Dee ^b   Hsieh, An Tsz ^a   Wang, Kun ^b   Lin, Jiunn Diann ^c   Lee, Li Hsiu ^b   Chu, Yi Min ^b   Hsiao, Fone Ching ^d   Pei, Chun ^e   Hsia, Te Lin ^b  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^e NAN KAI UNIVERSITY OF TECHNOLOGY   (Taiwan)

Author keywords

Disposal index; Frequently sampled intravenous glucose tolerance test; Gliclazide; Insulin sensitivity; Repaglinide

Indexed keywords

GLICLAZIDE; GLUCOSE; INSULIN; REPAGLINIDE; ANTIDIABETIC AGENT; CARBAMIC ACID DERIVATIVE; GLYCOSYLATED HEMOGLOBIN; LIPID; PIPERIDINE DERIVATIVE;

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RELEASE; INSULIN SENSITIVITY; INTRAVENOUS GLUCOSE TOLERANCE TEST; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; BLOOD; BLOOD PRESSURE; BODY MASS; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG EFFECT; GLUCOSE TOLERANCE TEST; INSULIN RESISTANCE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; TIME; TREATMENT OUTCOME;

ADULT; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; CARBAMATES; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GLICLAZIDE; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; LIPIDS; MALE; MIDDLE AGED; PIPERIDINES; TIME FACTORS; TREATMENT OUTCOME;

EID: 77953634464     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-010-0310-6     Document Type: Article

References (24)

1. Anonymous. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care, 20, 1183-1197 (1997).
2. Davies, M. J., Rayman, G., Grenfell, A., Gray, I. P., Day, J. L., and Hales, C. N., Loss of the first phase insulin response to intravenous glucose in subjects with persistent impaired glucose tolerance. Diabet. Med., 11, 432-436 (1994).
3. DeFronzo, R. A., Tobin, J. D., and Andres, R., Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am. J. Physiol., 237, E214-E223 (1979).
4. Fukushima, M., Usami, M., Ikeda, M., Nakai, Y., Taniguchi, A., Matsuura, T., Suzuki, H., Kurose, T., Yamada, Y., and Seino, Y., Insulin secretion and insulin sensitivity at different stages of glucose tolerance: a cross-sectional study of Japanese type 2 diabetes. Metabolism, 53, 831-835 (2004).
5. Galvin, P., Ward, G., Walters, J., Pestell, R., Koschmann, M., Vaag, A., Martin, I., Best, J. D., and Alford, F., A simple method for quantitation of insulin sensitivity and insulin release from an intravenous glucose tolerance test. Diabet. Med., 9, 921-928 (1992).
6. Kahn, S. E., The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes. Diabetologia, 46, 3-19 (2003).
7. Kolterman, O. G., Gray, R. S., Shapiro, G., Scarlett, J. A., Griffin, J., and Olefsky, J. M., The acute and chronic effects of sulfonylurea therapy in type II diabetic subjects. Diabetes, 33, 346-354 (1984).
8. Korytkowski, M., Thomas, A., Reid, L., Tedesco, M. B., Gooding, W. E., and Gerich, J., Glimepiride improves both first and second phases of insulin secretion in type 2 diabetes. Diabetes Care, 25, 1607-1611 (2002).
9. Korytkowski, M. T., Berga, S. L., and Horwitz, M. J., Comparison of the minimal model and the hyperglycemic clamp for measuring insulin sensitivity and acute insulin response to glucose. Metabolism, 44, 1121-1125 (1995).
10. Kosaka, K., Kuzuya, T., Yoshinaga, H., and Hagura, R., A prospective study of health check examinees for thedevelopment of non-insulin-dependent diabetes mellitus: relationship of the incidence of diabetes with the initial insulinogenic index and degree of obesity. Diabet. Med., 13, S120-S126 (1996).
11. McFadzean, A. J. and Yeung, R., Diabetes among the Chinese in Hong Kong. Diabetes, 17, 219-228 (1968).
12. Mehring, G. H., Coates, P. A., Brunel, P. C., Luzio, S. D., and Owens, D. R., Insulin sensitivity in type 2 diabetes: univariate and multivariate techniques to derive estimates of insulin sensitivity from the insulin modified intravenous glucose tolerance test (FSIGT). Comput. Methods Programs Biomed., 68, 161-176 (2002).
13. Meigs, J. B., Cupples, L. A., and Wilson, P. W., Parental transmission of type 2 diabetes: the Framingham Offspring Study. Diabetes, 49, 2201-2207 (2000).
14. O'Rahilly, S., Barroso, I., and Wareham, N. J., Genetic factors in type 2 diabetes: the end of the beginning? Science, 307, 370-373 (2005).
15. Ohmura, T., Ueda, K., Kiyohara, Y., Kato, I., Iwamoto, H., Nakayama, K., Nomiyama, K., Ohmori, S., Yoshitake, T., and Shinkawa, A., The association of the insulin resistance syndrome with impaired glucose tolerance and NIDDM in the Japanese general population: the Hisayama study. Diabetologia, 37, 897-904 (1994).
16. Qiao, Q., Nakagami, T., Tuomilehto, J., Borch-Johnsen, K., Balkau, B., Iwamoto, Y., and Tajima, N., International Diabetes Epidemiology Group; DECODA Study Group. Comparison of the fasting and the 2-h glucose criteria for diabetes in different Asian cohorts. Diabetologia, 43, 1470-1475 (2000).
17. Saad, M. F., Anderson, R. L., Laws, A., Watanabe, R. M., Kades, W. W., Chen, Y. D., Sands, R. E., Pei, D., Savage, P. J., and Bergman, R. N., A comparison between the minimal model and the glucose clamp in the assessment of insulin sensitivity across the spectrum of glucose tolerance. Insulin Resistance Atherosclerosis Study. Diabetes, 43, 1114-1121 (1994).
18. Sekikawa, A., Tominaga, M., Takahashi, K., Eguchi, H., Igarashi, M., Ohnuma, H., Sugiyama, K., Manaka, H., Sasaki, H., and Fukuyama, H., Prevalence of diabetes and impaired glucose tolerance in Funagata area, Japan. Diabetes Care, 16, 570-574 (1993).
19. Simonson, D. C., Ferrannini, E., Bevilacqua, S., Smith, D., Barrett, E., Carlson, R., and DeFronzo, R. A., Mechanism of improvement in glucose metabolism after chronic glyburide therapy. Diabetes, 33, 838-845 (1984).
20. Tripathy, D., Carlsson, M., Almgren, P., Isomaa, B., Taskinen, M. R., Tuomi, T., and Groop, L. C., Insulin secretion and insulin sensitivity in relation to glucose tolerance: lessons from the Botnia Study. Diabetes, 49, 975-980 (2000).
21. Tsu, S. H., Clinical features of diabetes in Taiwan. Diabetes Mellitus in Asia, ed. Baba, S., Goto, T., and Fukui, E., Exerpta Media, Amsterdam (1976).
22. Tusie Luna, M. T., Genes and type 2 diabetes mellitus. Arch. Med. Res., 36, 210-222 (2005).
23. Welch, S., Gebhart, S. S., Bergman, R. N., and Phillips, L. S., Minimal model analysis of intravenous glucose tolerance test-derived insulin sensitivity in diabetic subjects. J. Clin. Endocrinol. Metab., 71, 1508-1518 (1990).
24. Yki-Jarvinen, H., Toxicity of hyperglycaemia in type 2 diabetes. Diabetes Metab. Rev., 14(Suppl 1), S45-S50 (1998).